Literature DB >> 9215668

Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11.

P Reed1, F Cucca, S Jenkins, M Merriman, A Wilson, P McKinney, E Bosi, G Joner, K S Rønningen, K Rønningen, E Thorsby, D Undlien, T Merriman, A Barnett, S Bain, J Todd.   

Abstract

A region of linkage to type 1 diabetes has been defined on human chromosome 10p11-q11 (IDDM10; P = 0.0007) using 236 UK and 76 US affected sibpairs and a 1 cM resolution microsatellite marker map. Analysis by the transmission disequilibrium test (TDT) in 1159 families with at least one diabetic child, from the UK, the US, Norway, Sardinia and Italy provided additional support for linkage at D10S193 (P = 0.006, Pc = 0.17). Notably, 5.1 cM distal to D10S193, marker D10S588 also provided positive TDT results (P = 0.009, Pc = 0.25) but the allele under analysis was also preferentially transmitted to nonaffected siblings (P = 0.0008, Pc = 0.02). This allele was positively associated in an independent UK case control study and, importantly, was neutrally transmitted in control CEPH families. These results suggest a type 1 diabetes susceptibility locus on chromosome 10p11-q11 (provisionally designated IDDM10) and demonstrate the necessity of analysis of non affected siblings in disease families, as well as analysis of control families.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215668     DOI: 10.1093/hmg/6.7.1011

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  12 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Multilocus linkage tests based on affected relative pairs.

Authors:  H J Cordell; G C Wedig; K B Jacobs; R C Elston
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

3.  Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.

Authors:  N J Cox; B Wapelhorst; V A Morrison; L Johnson; L Pinchuk; R S Spielman; J A Todd; P Concannon
Journal:  Am J Hum Genet       Date:  2001-08-15       Impact factor: 11.025

Review 4.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

5.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

6.  Transmission disequilibrium, family controls, and great expectations.

Authors:  D J Schaid
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

7.  Significant linkage on chromosome 10p in families with bulimia nervosa.

Authors:  Cynthia M Bulik; B Devlin; Silviu-Alin Bacanu; Laura Thornton; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Allan S Kaplan; Michael Strober; D Blake Woodside; Andrew W Bergen; J Kelly Ganjei; Scott Crow; James Mitchell; Alessandro Rotondo; Mauro Mauri; Giovanni Cassano; Pamela Keel; Wade H Berrettini; Walter H Kaye
Journal:  Am J Hum Genet       Date:  2002-12-10       Impact factor: 11.025

8.  A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions.

Authors:  J Nerup; F Pociot
Journal:  Am J Hum Genet       Date:  2001-10-11       Impact factor: 11.025

9.  Application and interpretation of transmission/disequilibrium tests: transmission of HLA-DQ haplotypes to unaffected siblings in 526 families with type 1 diabetes.

Authors:  B A Lie; K S Ronningen; H E Akselsen; E Thorsby; D E Undlien
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

10.  IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.

Authors:  Fuencisla Matesanz; Alfredo Caro-Maldonado; Maria Fedetz; Oscar Fernández; Roger L Milne; Miguel Guerrero; Concepción Delgado; Antonio Alcina
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.